The Bio-Behavioral Core will advance high-impact, integrated biomedical, behavioral, and social science research in HIV prevention and care from conceptualization to proposal submission and from data collection to interpretation and dissemination. Although effective combination antiretroviral therapy (ART) can reduce HIV transmission, new infections continue to occur, and diagnoses surpass deaths each year. Every biomedical strategy for preventing and treating HIV infection (e.g., ART, PrEP, PEP, intravaginal rings, condoms, microbicides, and future vaccines and broadly neutralizing monoclonal antibodies] has behavioral components that influence efficacy and effectiveness. Unless biomedical strategies are acceptable, widely disseminated, and adhered to and take into consideration co-morbidities such as mental health and substance use and health and social disparities, their impact on the AIDS epidemic will be limited. The Bio-Behavioral Core will provide a comprehensive approach that integrates biomedical, behavioral and social science, and clinical perspectives for HIV prevention and treatment research, using Syndemics Theory as a guiding framework for advancing bio- behavioral research. The Core has three Specific Aims: (1) to stimulate high-impact bio-behavioral research on emerging priority topics at the interface of biomedical and behavioral science; (2) to provide expertise on selection of biological measures, sample collection and assay, and interpretation of resulting data; and (3) to prioritize clinical perspectives through partnerships with HIV and non-HIV care providers. The Bio-Behavioral Core will accomplish its Aims through a range of functions that include expert consultation to HIV Center researchers on research design, intervention development, biomarkers, social science theories, and research partnerships with providers; Scientific Working Groups, integrated diverse teams of biomedical, clinical, and social science researchers who come together to develop competitive research proposals that meet the most pressing clinical, scientific, and policy challenges; and annual Symposia that bring preeminent researchers to the HIV Center for intensive exploration of selected pressing scientific dilemmas to stimulate new scientific questions and, ultimately, multidisciplinary research grant proposals. We will identify shared scientific goals that bridge disciplinary silos; build collaborative interdisciplinary teams to address these goals; and support an integrated bio-behavioral research agenda. The Core Director will be Laurie Bauman, Ph.D., a sociologist, Professor of Pediatrics, and Director of the Prevention Intervention Research Center at the Albert Einstein College of Medicine. Core Co-Director, Michael Yin, M.D., is an Associate Professor of Medicine at Columbia University who manages care for PLWH, provides PrEP-related services, and is an investigator in the CUMC AIDS Clinical Trials Group (ACTG). Through the strengths of its Members and Affiliates in behavioral, social, and biomedical sciences and clinical research and care, the Bio- Behavioral Core will provide essential infrastructure to support a Center-wide learning community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH043520-33
Application #
10090640
Study Section
Special Emphasis Panel (ZMH1)
Project Start
1987-09-30
Project End
2023-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
33
Fiscal Year
2021
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Kelvin, Elizabeth A; George, Gavin; Mwai, Eva et al. (2018) Offering Self-administered Oral HIV Testing as a Choice to Truck Drivers in Kenya: Predictors of Uptake and Need for Guidance While Self-testing. AIDS Behav 22:580-592
Davis, Alissa; Goddard-Eckrich, Dawn; Dasgupta, Anindita et al. (2018) Risk factors associated with sexually transmitted infections among women under community supervision in New York City. Int J STD AIDS 29:766-775
Hampanda, Karen M; Rael, Christine Tagliaferri (2018) HIV Status Disclosure Among Postpartum Women in Zambia with Varied Intimate Partner Violence Experiences. AIDS Behav 22:1652-1661
Parcesepe, Angela; Tymejczyk, Olga; Remien, Robert et al. (2018) HIV-Related Stigma, Social Support, and Psychological Distress Among Individuals Initiating ART in Ethiopia. AIDS Behav 22:3815-3825
Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2018) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav 22:2026-2032
Meyers, Kathrine; Wu, Yumeng; Qian, Haoyu et al. (2018) Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China. AIDS Behav 22:1217-1227
Bauermeister, José A; Giguere, R; Leu, C S et al. (2018) Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men. AIDS Behav 22:412-420
Fogel, Jessica M; Sandfort, Theodorus; Zhang, Yinfeng et al. (2018) Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. AIDS Behav :
Davis, Alissa; McCrimmon, Tara; Dasgupta, Anindita et al. (2018) Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Int J Drug Policy 62:43-50
Carballo-Dieguez, Alex; Giguere, Rebecca; Lentz, Cody et al. (2018) Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche. AIDS Behav :

Showing the most recent 10 out of 714 publications